The global assisted reproductive technology (ART) market size is likely to gain traction owing to the increasing cases of infertility worldwide. The Centres for Disease Control and Prevention states an average of 306,174 ART cycles was undertaken in 2018 within fertility clinics in the United States. As per a recent study by Fortune Business Insights titled, “Assisted Reproductive Technology Market Size, Share & Industry Analysis, By Technique (In-Vitro Fertilization (IVF), Artificial Insemination (AI-IUI), Frozen Embryo Transfer (FET), and Others), By Procedure, By End User and Regional Forecast, 2019-2026,” the market is expected to reach USD 45.06 billion by the end of 2026 from USD 21.32 billion earned in 2018, by exhibiting a CAGR of 9.8% between 2019 to 2026
For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/industry-reports/assisted-r...
Fortune Business Insights™ lists out the names of market manufacturers. They are as follows:
European Sperm Bank
Apollo Hospitals Enterprise Ltd.
Bloom IVF Centre
Carolinas Fertility Institute
Monash IVF Group
Europe Earned Highest Share Attributable to Rising Prevalence of Infertility Cases
Geographically, Europe earned USD 8.78 billion in 2018 and gained the highest ART market share on account of the increasing prevalence of infertility cases in the region, followed by increasing demand for assisted reproductive technology for conceiving. Germany, the UK, Spain, France, and Denmark are the most active nations for fertility services in this region. Additionally, the North America market will witness significant growth on account of increasing adoption of technologically advanced fertility services in the U.S. Besides this, Asia Pacific market will also witness rapid growth in the coming years on account of the increasing disposable incomes of people, developing healthcare infrastructure and reduction in socio-ethical stigma among the local population.
European Sperm Bank, California Cryobank, and Bloom IVF Centre are Holding Dominance Owing to Strong Portfolio
Players operating in the market for assisted reproductive technology (ART) are engaged in various strategies such as strong network and portfolio, and introduction of better-advanced fertility procedures at efficient prices for gaining momentum in the market. Currently, players namely California Cryobank, Bloom IVF Centre, and European Sperm Bank are dominating the market with their strong portfolio.